Bristol-Myers Squibb: Earnings Champion Valued Like A Loser (NYSE:BMY)

Core Insights - Bristol-Myers Squibb Company's (NYSE: BMY) share price has experienced weakness since "Liberation Day," reflecting broader challenges within the healthcare industry due to significant political uncertainty [1] Company Performance - The performance of Bristol-Myers Squibb is closely tied to the overall healthcare sector, which is currently facing political uncertainties impacting investor sentiment [1] Market Context - The healthcare industry as a whole is experiencing volatility, which is mirrored in the stock performance of Bristol-Myers Squibb [1]